Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study

Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study

Most patients with asthma can control their symptoms with a basic standard of medical care and with maintenance and rescue medication. However, between 5% and 10% of asthmatics worldwide do not achieve control of their symptoms and have recurrent exacerbations and respiratory difficulties. The objec...

Full description

Bibliographic Details
Main Authors: Susana Rojo-Tolosa, María Victoria González-Gutiérrez, José Antonio Sánchez-Martínez, Gonzalo Jiménez-Gálvez, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, Alberto Jiménez-Morales, Cristina Pérez-Ramírez, Concepción Morales-García
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
severe uncontrolled asthma
omalizumab
effectiveness
biomarkers
Online Access:https://www.mdpi.com/1999-4923/15/2/523

Similar Items

Similar Items